Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Christophe Hennequin"'
Publikováno v:
Cancer/Radiothérapie. 25:660-662
Management of high-risk prostate cancers is still a subject of debate, because of the lack of randomized trial comparing surgery and radiotherapy. If external beam radiotherapy is proposed, it must be associated with a long-term androgen deprivation
Autor:
François Desgrandchamps, Laetitia Vercellino, Pierre Mongiat-Artus, Vincent Ravery, Stéphane Culine, Pascal Merlet, Paul Meria, Eric de Kerviler, Christophe Hennequin, Laurent Quero
Publikováno v:
Clinical nuclear medicine. 40(11)
Purpose The aim of this study was to assess the value of combining MRI and 18F-fluorocholine (FCH) PET/CT for patients with a biochemical relapse (BR) after prostate radiotherapy or brachytherapy. Patients and Methods All patients with a BR (BR defin
Autor:
Mehdi Mokhtar Ariane, Christophe Hennequin, Xavier Rebillard, Pascal Rischmann, Pierre Mongiat-Artus, Guillaume Ploussard, Bernard Malavaud
Publikováno v:
World journal of urology. 33(11)
Through a cross-sectional survey, we tried to assess whether practices of urologists and radiation oncologists are uniform when faced with similar clinical situations. A self-administered questionnaire was mailed to all French urologists and radiatio
Autor:
Christophe Hennequin, Pierre Mongiat-Artus, Vincent Ravery, Paul Meria, Eric de Kerviler, Stéphane Culine, Laetitia Vercellino, François Desgrandchamps, Laurent Quero
Publikováno v:
Journal of Clinical Oncology. 34:23-23
23 Background: In our institution, as soon as biochemical relapse (BR; nadir PSA + 2 ng/ml) occurred after external beam radiotherapy (EBRT) or brachytherapy (BT), 18-fluorocholine-PET-CT (18-FCH-PET) with or without multiparametric prostate MRI are